CHARLES SCHWAB INVESTMENT MANAGEMENT INC - ATYR PHARMA INC ownership

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of ATYR PHARMA INC
ValueSharesWeighting
Q3 2023$42,169
-26.9%
26,6890.0%0.00%
Q2 2023$57,648
+2.9%
26,6890.0%0.00%
Q1 2023$56,047
+155.9%
26,689
+166.9%
0.00%
Q4 2022$21,900
-27.0%
10,0000.0%0.00%
Q3 2022$30,000
+3.4%
10,0000.0%0.00%
Q2 2022$29,000
-46.3%
10,0000.0%0.00%
Q1 2022$54,000
-28.0%
10,0000.0%0.00%
Q4 2021$75,00010,0000.00%
Other shareholders
ATYR PHARMA INC shareholders Q4 2023
NameSharesValueWeighting ↓
Alyeska Investment Group, L.P. 725,984$3,223,0000.05%
Marquette Asset Management, LLC 18,848$84,0000.03%
FEDERATED HERMES, INC. 1,615,000$7,171,0000.02%
VIKING GLOBAL INVESTORS LP 587,444$2,608,0000.01%
TWO SIGMA INVESTMENTS, LP 132,123$587,0000.00%
OPPENHEIMER & CO INC 18,343$81,0000.00%
Renaissance Technologies 365,830$1,624,0000.00%
TWO SIGMA ADVISERS, LP 80,950$359,0000.00%
FMR LLC 1,402,874$6,229,0000.00%
ACADIAN ASSET MANAGEMENT LLC 67,964$302,0000.00%
View complete list of ATYR PHARMA INC shareholders